No Data
MEILLEUREHEALTH (02327.HK) held a Board of Directors meeting on March 28 to review and approve the annual performance.
On March 12, Gelonghui announced that MEILLEUREHEALTH (02327.HK) will hold a Board of Directors meeting on March 28, 2025 (Friday) to review and approve (including) the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and to consider the payment of a final dividend (if any).
MEILLEUREHEALTH (02327.HK) was purchased by Executive Director Zhou Xuzhou with an additional shareholding of 2.916 million shares.
On January 24, according to the latest equity disclosure information from the Hong Kong Stock Exchange, on January 21, 2025, MEILLEUREHEALTH (02327.HK) was increased by Executive Director Zhou Xuzhou in the market, acquiring 2.916 million shares at an average price of HK$0.2746 per share, involving approximately HK$0.8007 million. After the Shareholding, Zhou Xuzhou's latest number of shares held increased to 2,396,920,761 shares, with the shareholding ratio rising from 58.48% to 58.55%.
Zhichun Hong Kong stock buyback Statistics | January 22
Hong Kong stock repurchase Statistics | January 22.
Meilleure Health Unit to Sell Australia Property to CEO
MEILLEUREHEALTH (02327) intends to sell its property in Australia to executive director Zhou Wenchuan.
MEILLEUREHEALTH (02327) announced that on January 10, 2025, the company's indirect wholly-owned subsidiary U-Ho...
Express News | Meilleure Health International Industry - Unit to Sell Residential Development Project in Australia for AUD1.4 Mln
Meilleure Health International Industry Group Limited's (HKG:2327) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
